“Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer” (2015) Journal of Analytical Oncology, 4(1), pp.  44–51. doi:10.6000/1927-7229.2015.04.01.8.